Excretion Pathways Limited data on combined excretion indicates[21]: Primarily renal elimination of peptide fragments from all components Hepatic metabolism contributes to overall clearance Copper recycling through normal physiological pathways (GHK-Cu component) No evidence of accumulation in chronic dosing studies of individual components BPC-157 detectable in urine for up to 4 days
Niclosamide has such a limited amount in solution
Three cycles in now, and the changes have been gradual but real
The potential cost of using a compromised solution is immense
Lead Researcher Spotlight Professor Predrag Sikiric, MD, PhD (BPC-157 Primary Investigator) Department of Pharmacology University of Zagreb School of Medicine, Zagreb, Croatia Professor Predrag Sikiric has been the primary investigator for BPC-157 research since the 1990s, leading the team that isolated and characterized this peptide from human gastric juice
BPC-157 Capsules are an encapsulated synthetic pentadecapeptide research formulation for in vitro laboratory investigation
